RUNX1 and acute myeloid leukemia: For instance, the AML1-ETO fusion protein is a critical oncogenic driver of acute myeloid leukemia (AML), but this fusion protein alone cannot transform normal cells into malignant cells, suggesting that other factors are required for tumorigenesis (Mulloy et al., 2002).